AU Patent

AU2003213684B2 — Methods of inducing terminal differentiation

Assigned to Merck HDAC Research LLC · Expires 2007-04-26 · 19y expired

What this patent protects

Patent listed against Zolinza.

Drugs covered by this patent

Patent Metadata

Patent number
AU2003213684B2
Jurisdiction
AU
Classification
—
Expires
2007-04-26
Drug substance claim
No
Drug product claim
No
Assignee
Merck HDAC Research LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.